Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
| Autor: | Bagheri, Vahid, Askari, Azam, Arababadi, Mohammad Kazemi, Kennedy, Derek |
|---|---|
| Zdroj: | In Human Immunology June 2014 75(6):549-554 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect